Dexcel Pharma

Found 1 recent publications

Aug 11, 2026

Markets

Fortissimo Fund Sells CTS Pharmaceutical Operations to Dexcel Pharma for 250 Million Shekels

The pharmaceutical company CTS is being sold to Dexcel Pharma for approximately 250 million shekels. The acquisition covers only the pharmaceutical operations, while other business units remain separate.

Showing latest 50 articles for this tag